Cargando…
Cyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatment
Overexpression of G1-S regulators cyclin D1 or cyclin A is frequently observed in breast cancer and is also to result in ligand-independent activation of oestrogen receptor in vitro. This might therefore, provide a mechanism for failure of tamoxifen treatment. We examined by immunohistochemical stai...
Autores principales: | Michalides, R, van Tinteren, H, Balkenende, A, Vermorken, J B, Benraadt, J, Huldij, J, van Diest, P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375223/ https://www.ncbi.nlm.nih.gov/pubmed/11875707 http://dx.doi.org/10.1038/sj.bjc.6600072 |
Ejemplares similares
-
Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients
por: Stendahl, M, et al.
Publicado: (2004) -
The influence of tamoxifen treatment on the oestrogen receptor in metachronous contralateral breast cancer
por: Kaas, R, et al.
Publicado: (2003) -
Tamoxifen induction of angiogenic factor expression in endometrium
por: Hague, S, et al.
Publicado: (2002) -
Higher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistance
por: Luo, L-Y, et al.
Publicado: (2002) -
Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma
por: Rohloff, J, et al.
Publicado: (2002)